These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35132446)

  • 1. Minimal change disease and acute interstitial nephritis following SARS-CoV-2 BNT162b2 vaccination.
    Jongvilaikasem P; Rianthavorn P
    Pediatr Nephrol; 2022 Jun; 37(6):1419-1421. PubMed ID: 35132446
    [No Abstract]   [Full Text] [Related]  

  • 2. Report of two cases of minimal change disease following vaccination for COVID -19.
    Baskaran K; Cohen AWS; Weerasinghe N; Vilayur E
    Nephrology (Carlton); 2022 Jan; 27(1):111-112. PubMed ID: 34779088
    [No Abstract]   [Full Text] [Related]  

  • 3. Two adolescent cases of acute tubulointerstitial nephritis after second dose of COVID-19 mRNA vaccine.
    Choi JH; Kang KS; Han KH
    Hum Vaccin Immunother; 2022 Nov; 18(5):2059308. PubMed ID: 35385678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Interstitial Nephritis with Glomerular Capillary IgA Deposition Following SARS-CoV-2 mRNA Vaccination.
    Hishida E; Ono Y; Oe K; Imai T; Yoshizawa H; Nakaya T; Kawata H; Akimoto T; Saito O; Nagata D
    Intern Med; 2023; 62(16):2381-2387. PubMed ID: 37587055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severely impaired humoral response against SARS-CoV-2 variants of concern following two doses of BNT162b2 vaccine in patients with systemic lupus erythematosus (SLE).
    Mageau A; Ferré VM; Goulenok T; Charpentier C; Delory N; Francois C; Houhou-Fidouh N; Papo T; Descamps D; Sacre K
    Ann Rheum Dis; 2022 Aug; 81(8):1194-1196. PubMed ID: 35396228
    [No Abstract]   [Full Text] [Related]  

  • 6. Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases.
    Hartley JL; Bailey N; Sharma A; Shawki H
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35246429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute interstitial nephritis following SARS-CoV-2 virus vaccination.
    Liew SK; Nair B; So B; Ponnusamy A; Bow A; Woywodt A
    Clin Nephrol; 2022 Apr; 97(4):242-245. PubMed ID: 35113012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute interstitial nephritis after vaccination with BNT162b2.
    Rieckmann S; Seibert FS; Hogeweg M; Bertram S; Doevelaar AAN; Amann K; Babel N; Westhoff TH
    J Nephrol; 2022 Apr; 35(3):779-782. PubMed ID: 35254639
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune-mediated necrotizing myopathy after BNT162b2 vaccination in a patient with antibodies against receptor-binding domain of SARS-CoV-2 and signal recognition particle.
    Dodig D; Fritzler MJ; Naraghi A; Tarnopolsky MA; Lu JQ
    Muscle Nerve; 2022 Apr; 65(4):E11-E13. PubMed ID: 34970746
    [No Abstract]   [Full Text] [Related]  

  • 10. Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine.
    Ruhe J; Schnetzke U; Kentouche K; Prims F; Baier M; Herfurth K; Schlosser M; Busch M; Hochhaus A; Wolf G
    Ann Hematol; 2022 Mar; 101(3):717-719. PubMed ID: 34309715
    [No Abstract]   [Full Text] [Related]  

  • 11. Exacerbation of Minimal Change Disease Following mRNA COVID-19 Vaccination.
    Pirzadeh A; Emami S; Zuckerman JE; Nobakht N
    Am J Case Rep; 2023 Nov; 24():e941621. PubMed ID: 37941318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De Novo Minimal Change Disease following Vaccination with the Pfizer/BioNTech SARS-CoV-2 Vaccine in a Living Kidney Donor.
    Marinaki S; Kolovou K; Liapis G; Skalioti C; Tsiakas S; Boletis I
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal change disease following vaccination for SARS-CoV-2.
    Mancianti N; Guarnieri A; Tripodi S; Salvo DP; Garosi G
    J Nephrol; 2021 Aug; 34(4):1039-1040. PubMed ID: 34143368
    [No Abstract]   [Full Text] [Related]  

  • 14. Piroxicam-induced acute interstitial nephritis and minimal-change nephrotic syndrome.
    Fellner SK
    Am J Nephrol; 1985; 5(2):142-3. PubMed ID: 3993703
    [No Abstract]   [Full Text] [Related]  

  • 15. Inflammatory Bowel Disease Triggered by BNT162b2 mRNA Vaccination for SARS-CoV-2.
    Shimodaira Y; Watanabe K; Takahashi S; Koizumi S; Iijima K
    Inflamm Bowel Dis; 2022 Jun; 28(6):e75. PubMed ID: 34922342
    [No Abstract]   [Full Text] [Related]  

  • 16. Generalized erythrodermic psoriasis triggered by vaccination against severe acute respiratory syndrome Coronavirus 2.
    Tran TB; Pham NTU; Phan HN; Nguyen HT
    Dermatol Ther; 2022 Jun; 35(6):e15464. PubMed ID: 35306720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal change nephropathy and interstitial nephritis associated with diclofenac.
    Wolters J; van Breda Vriesman PJ
    Neth J Med; 1985; 28(8):311-4. PubMed ID: 4047264
    [No Abstract]   [Full Text] [Related]  

  • 18. New-Onset Acute Interstitial Nephritis Post-SARS-CoV-2 Infection and COVID-19 Vaccination: A Panoramic Review.
    Wang Y; Yang L; Xu G
    J Epidemiol Glob Health; 2023 Dec; 13(4):615-636. PubMed ID: 37870719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal-change disease and interstitial nephritis secondary to non-steroidal anti-inflammatory drugs (naproxen).
    Baccouche K; Alaya Z; Azzabi A; Ben Abdelkarim S; Belghali S; El Amri N; Zeglaoui H; Slim R; Bouajina E
    Therapie; 2016 Oct; 71(5):515-517. PubMed ID: 27203163
    [No Abstract]   [Full Text] [Related]  

  • 20. First and fatal case of autoimmune acquired factor XIII/13 deficiency after COVID-19/SARS-CoV-2 vaccination.
    Shimoyama S; Kanisawa Y; Ono K; Souri M; Ichinose A
    Am J Hematol; 2022 Feb; 97(2):243-245. PubMed ID: 34856014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.